APA (7th ed.) Citation

J, F., AG, W., E, P., B, T., K, B., S, C., . . . EM, V. A. (2025). Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer. Nature communications, 16(1), 10704. https://doi.org/10.1038/s41467-025-66659-y

Chicago Style (17th ed.) Citation

J, Fu, et al. "Cellular Reprogramming During Anti-PD-1 and Chemotherapy Treatment in Early-stage Primary Hormone Receptor-positive Breast Cancer." Nature Communications 16, no. 1 (2025): 10704. https://doi.org/10.1038/s41467-025-66659-y.

MLA (9th ed.) Citation

J, Fu, et al. "Cellular Reprogramming During Anti-PD-1 and Chemotherapy Treatment in Early-stage Primary Hormone Receptor-positive Breast Cancer." Nature Communications, vol. 16, no. 1, 2025, p. 10704, https://doi.org/10.1038/s41467-025-66659-y.